I Golan1, A Waldeck, U Baumert, J Strutz, D Müssig. 1. Poliklinik für Kieferorthopädie des Klinikum der Universität Regensburg, Regensburg. ilan.golan@klinik.uni-regensburg.de
Abstract
BACKGROUND: The description of the otorhinolaryngeal and craniofacial anomalies in patients with cleidocranial dysplasia. METHODS: For this study, 26 patients with cleidocranial dysplasia were examined after their medical history had been recorded. The main focus was placed on otorhinolaryngological and orthodontic findings. RESULTS: The portion of spontaneous mutations in our patient population was 46.1%. All patients exhibited otorhinolaryngological and craniofacial anomalies. While single ENT-anomalies were expressed in 76.9%-92.3% of the patients, the craniofacial findings were distributed over 84.6%-92.3%. CONCLUSION: The expression of this rare disorder is variable and its symptomatology not always distinct. Otorhinolaryngological and craniofacial anomalies are often apparent. Appropriate treatment can significantly contribute to an improvement in the patient's quality of life. In cases of ambiguous findings, we recommend consultation with an experienced clinician as well as genetic counselling.
BACKGROUND: The description of the otorhinolaryngeal and craniofacial anomalies in patients with cleidocranial dysplasia. METHODS: For this study, 26 patients with cleidocranial dysplasia were examined after their medical history had been recorded. The main focus was placed on otorhinolaryngological and orthodontic findings. RESULTS: The portion of spontaneous mutations in our patient population was 46.1%. All patients exhibited otorhinolaryngological and craniofacial anomalies. While single ENT-anomalies were expressed in 76.9%-92.3% of the patients, the craniofacial findings were distributed over 84.6%-92.3%. CONCLUSION: The expression of this rare disorder is variable and its symptomatology not always distinct. Otorhinolaryngological and craniofacial anomalies are often apparent. Appropriate treatment can significantly contribute to an improvement in the patient's quality of life. In cases of ambiguous findings, we recommend consultation with an experienced clinician as well as genetic counselling.
Authors: M Goseki-Sone; H Orimo; A Watanabe; R Hamatani; M Yokozeki; K Ohyama; T Kuroda; H Watanabe; H Miyazaki; T Shimada; S Oida Journal: J Bone Miner Metab Date: 2001 Impact factor: 2.626
Authors: I Golan; U Baumert; H Wagener; J Dauwerse; M Preising; B Lorenz; H Niederdellmann; D Müssig Journal: Orthod Craniofac Res Date: 2002-11 Impact factor: 1.826
Authors: I Quack; B Vonderstrass; M Stock; A S Aylsworth; A Becker; L Brueton; P J Lee; F Majewski; J B Mulliken; M Suri; M Zenker; S Mundlos; F Otto Journal: Am J Hum Genet Date: 1999-11 Impact factor: 11.025